Related Experiment Videos
Opioid-like immunoreactants in human cervical cancer
B Ottesen1, K Jacobsen, A Andresen
1Department of Molecular Cell Biology, State Serum Institute, Copenhagen, Denmark.
Gynecologic Oncology
|February 1, 1990
Summary
Human cervical carcinomas often contain opioid peptides, suggesting a role in tumor growth. Normal cervical tissue lacks these opioid peptides, indicating a potential link between their presence and cancer progression.
Area of Science:
- Oncology
- Neuroendocrinology
- Immunology
Background:
- Cervical carcinoma cell lines can produce polypeptide hormones.
- Opioid peptides are known immunoregulators.
- Neuropeptide Y (NPY) and Peptide Histidine Methionine (PHM) are present in normal cervical tissue.
Purpose of the Study:
- To investigate the presence and localization of opioid peptides in human cervical carcinomas.
- To examine the expression of NPY and PHM in cervical tumors.
- To explore the potential role of opioid peptides in cervical cancer growth.
Main Methods:
- Immunocytochemistry using the PAP method on formalin-fixed, paraffin-embedded cervical tissue.
- Utilized antisera recognizing the common opioid peptide sequence (Tyr-Gly-Gly-Phe).
- Specific antisera were used to detect NPY and PHM.
Main Results:
- Opioid-like immunoreactivity was detected in 27 out of 40 cervical carcinomas.
- No opioid-like immunoreactivity was observed in 12 normal cervical specimens.
- No NPY-like or PHM-like immunoreactivity was found in any of the tumors, suggesting a loss of local peptidergic innervation.
Conclusions:
- Cervical carcinoma growth is associated with opioid peptide production.
- The absence of NPY and PHM suggests destruction of local peptidergic innervation during cancer progression.
- Opioid peptides may play a significant role in regulating the growth of human cervical carcinoma.